Belite Bio
BLTE
156.08
+0.47
+0.30%
Belite Bio
US · BLTE
#1866 by market cap
Listed 2022
156.08
+0.47
+0.30%
Live - 5344 symbols - heartbeat 390s ago
· 2026-10-08 06:30
Pre-market
155.99
-0.06%
After-hours
156.08
0.00%
- Market cap
- 6.29B
- P/E (TTM)i
- -56.96
- P/Bi
- 8.09
- EPSi
- -2.31
- Div yieldi
- 0.00%
- 52W posi
- 64%
Reader sentiment
Are you bullish or bearish on BLTE?
Anonymous reader poll. Unscientific, not investment advice.
Analyst consensus 7 analysts
Buy
Avg price target
236.86 +51.8%
Price target rangecurrent 156.08
Low200.00
Avg236.86
High303.00
Buy 100%
Hold 0%
Sell 0%
Recent ratings (25)
| Date | Firm | Analyst | Rating | Target |
|---|---|---|---|---|
| 2026-09-09 | Mizuho Securities | -- | BUY | 234.00 |
| 2026-09-09 | H.C. Wainwright | -- | BUY | 245.00 |
| 2026-09-08 | H.C. Wainwright | -- | BUY | 245.00 |
| 2026-09-04 | CCORF | -- | BUY | 303.00 |
| 2026-09-04 | Mizuho Securities | -- | BUY | 220.00 |
| 2026-09-03 | H.C. Wainwright | -- | BUY | 214.00 |
| 2026-09-02 | BofA Securities | -- | BUY | 200.00 |
| 2026-08-31 | Mizuho Securities | -- | BUY | 220.00 |
| 2026-08-17 | Morgan Stanley | -- | BUY | 206.00 |
| 2026-08-14 | Cantor Fitzgerald | -- | BUY | 270.00 |
| 2026-08-14 | Mizuho Securities | -- | BUY | 220.00 |
| 2026-08-14 | Maxim Group | -- | BUY | 200.00 |
| 2026-08-14 | BofA Securities | -- | BUY | -- |
| 2026-08-14 | Morgan Stanley | -- | BUY | 201.00 |
| 2026-08-14 | H.C. Wainwright | -- | BUY | 214.00 |
| 2026-08-13 | Cantor Fitzgerald | -- | BUY | 270.00 |
| 2026-08-12 | H.C. Wainwright | -- | BUY | 214.00 |
| 2026-08-11 | Cantor Fitzgerald | -- | BUY | 266.00 |
| 2026-07-22 | H.C. Wainwright | -- | BUY | 200.00 |
| 2026-07-13 | Mizuho Securities | -- | BUY | 215.00 |
| 2026-06-16 | H.C. Wainwright | -- | BUY | 200.00 |
| 2026-06-15 | BofA Securities | -- | BUY | 200.00 |
| 2026-06-15 | H.C. Wainwright | -- | BUY | 200.00 |
| 2026-05-27 | Maxim Group | -- | BUY | 200.00 |
| 2026-05-26 | Mizuho Securities | -- | BUY | 215.00 |
Quant vs Street three independent views, side by side
Momentum strategy signal
Sell
Analyst consensus
Buy
Signals diverge - worth digging into why.
Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.
Price target trend monthly average, last 3 years
Earnings history price reaction on the day
| Period | Report date | Session | Actual move |
|---|---|---|---|
| 2026/Q2 | 2026-08-13 | After close | -2.09% |
| 2026/Q1 | 2026-05-20 | -- | +0.62% |
| 2025/Q4 | 2026-03-02 | After close | -5.46% |
| 2025/Q3 | 2025-11-10 | After close | -9.87% |
| 2025/Q2 | 2025-08-11 | After close | +4.65% |
| 2025/Q1 | 2025-05-14 | After close | +8.88% |
| 2024/Q4 | 2025-03-17 | After close | +0.84% |
| 2024/Q3 | 2024-11-12 | After close | +1.33% |
| 2024/Q2 | 2024-08-12 | After close | +3.73% |
| 2024/Q1 | 2024-05-14 | After close | +1.07% |
| 2023/Q4 | 2024-03-12 | After close | -2.61% |
| 2023/Q2 | 2023-08-09 | After close | +6.24% |
Quote time 2026-10-08 06:30:46 · For reference only, not investment advice and not tailored to your situation.